Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study

Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study

Objective To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for the efficacy and prognosis of programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors in driver-gene-negative advanced non-small-cell lung cancer...

Full description

Bibliographic Details
Main Authors: Qi Yuan MD, Chunhua Xu MD, Wei Wang MD, Qian Zhang MD
Format: Article
Language:English
Published: SAGE Publishing 2024-04-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338241246651

Internet

https://doi.org/10.1177/15330338241246651

Similar Items